Dr. Peter Kim, the Director of Therapeutics Research Program at the Division of AIDS, NIH/NIAID visits MakBRC
On the 18th June 2024, Makerere University Biomedical Research Center (MakBRC) was honored to host a distinguished guest Dr. Peter Kim, MD who is the Director of the Therapeutics Research Program at the Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID). His visit provided a unique opportunity for the research community of the College of Health Sciences-Makerere University to engage with one of the leading experts in the field of HIV/AIDS research. In lead with the Managing Director and Head of Research and Innovations MakBRC, Professor Moses Joloba and Dr. Ivan Mwebaza respectively, together with other scientists and researchers, Dr. Peter Kim was given a tour around MakBRC and the College of Health Sciences. Among the so many facilities he visited were the Genomics, Molecular and Immunology Laboratories and the IBRH3AU Biorespository. Dr. Peter Kim was over joyed to see the so much infectious disease research being undertaken and the available resources to support the same. To close off the visit, Dr. Peter Kim gave a presentation; sharing valuable insights into the latest advancements in therapeutic research, emphasizing groundbreaking approaches and ongoing efforts to combat infectious diseases globally. The presentation was very interactive and interesting as it saw so many vibrant committed young scientists engaging with the Director Therapeutics Research Program at the Division of AIDS, NIAID.
We as MakBRC commit to fostering collaborations with esteemed institutions like NIAID to enhance our understanding of infectious diseases and accelerate progress towards effective treatments. We extend our heartfelt thanks to Dr. Peter Kim, MD, Director of the Therapeutics Research Program at the Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID) for his visit and enlightening presentation and looking forward to future collaborations that will further enrich our research endeavors.
